Restoring insulin production for type 1 diabetes
- 28 November 2012
- journal article
- review article
- Published by Wiley in Journal of Diabetes
- Vol. 4 (4) , 319-331
Abstract
Current therapies for the treatment of type 1 diabetes include daily administration of exogenous insulin and, less frequently, whole‐pancreas or islet transplantation. Insulin injections often result in inaccurate insulin doses, exposing the patient to hypo‐ and/or hyperglycemic episodes that lead to long‐term complications. Islet transplantation is also limited by lack of high‐quality islet donors, early graft failure, and chronic post‐transplant immunosuppressive treatment. These barriers could be circumvented by designing a safe and efficient strategy to restore insulin production within the patient’s body. Porcine islets have been considered as a possible alternative source of transplantable insulin‐producing cells to replace human cadaveric islets. More recently, embryonic or induced pluripotent stem cells have also been examined for their ability to differentiate in vitro into pancreatic endocrine cells. Alternatively, it may be feasible to generate new β‐cells by ectopic expression of key transcription factors in endogenous non‐β‐cells. Finally, engineering surrogate β‐cells by in vivo delivery of the insulin gene to specific tissues is also being studied as a possible therapy for type 1 diabetes. In the present review, we discuss these different approaches to restore insulin production.Keywords
This publication has 150 references indexed in Scilit:
- Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cellsMechanisms of Development, 2011
- Remission of Diabetes by Insulin Gene Therapy Using a Hepatocyte-specific and Glucose-responsive Synthetic PromoterMolecular Therapy, 2011
- The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β CellsCell, 2009
- Neurogenin3 Is Sufficient for Transdetermination of Hepatic Progenitor Cells into Neo-Islets In Vivo but Not Transdifferentiation of HepatocytesDevelopmental Cell, 2009
- AAV8-mediated Gene Transfer of Interleukin-4 to Endogenous β-Cells Prevents the Onset of Diabetes in NOD MiceMolecular Therapy, 2008
- Detailed molecular analysis of the induction of the L-PK gene by glucoseBiochemical and Biophysical Research Communications, 2008
- Insulin-secreting L-cells for the treatment of insulin-dependent diabetesBiochemical and Biophysical Research Communications, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapyDiabetologia, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006